Michael V. Tullius

1.3k total citations
19 papers, 1.0k citations indexed

About

Michael V. Tullius is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Michael V. Tullius has authored 19 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 7 papers in Epidemiology and 6 papers in Molecular Biology. Recurrent topics in Michael V. Tullius's work include Tuberculosis Research and Epidemiology (6 papers), Mycobacterium research and diagnosis (4 papers) and Carbohydrate Chemistry and Synthesis (3 papers). Michael V. Tullius is often cited by papers focused on Tuberculosis Research and Epidemiology (6 papers), Mycobacterium research and diagnosis (4 papers) and Carbohydrate Chemistry and Synthesis (3 papers). Michael V. Tullius collaborates with scholars based in United States, Canada and Australia. Michael V. Tullius's co-authors include Marcus A. Horwitz, Günter Harth, Bradford W. Gibson, Robert S. Munson, Jacqueline M. Kimmey, Celia W. Goulding, Barbara Jane Dillon, Julian P. Whitelegge, Robert P. Morse and Angelina Iniguez and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Immunity.

In The Last Decade

Michael V. Tullius

19 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael V. Tullius United States 16 501 414 322 170 114 19 1.0k
Yaqi Zhu China 9 457 0.9× 657 1.6× 470 1.5× 149 0.9× 122 1.1× 33 1.1k
Wanyan Deng China 18 721 1.4× 465 1.1× 460 1.4× 266 1.6× 82 0.7× 44 1.3k
Pascale Peyron France 13 648 1.3× 785 1.9× 629 2.0× 323 1.9× 140 1.2× 15 1.6k
Georgiana E. Purdy United States 20 545 1.1× 853 2.1× 809 2.5× 212 1.2× 234 2.1× 40 1.6k
Olivia Vergnolle United States 15 758 1.5× 253 0.6× 197 0.6× 213 1.3× 66 0.6× 18 1.1k
Sonia Escaich France 22 514 1.0× 259 0.6× 140 0.4× 138 0.8× 242 2.1× 32 1.1k
Alain Vercellone France 16 393 0.8× 245 0.6× 299 0.9× 414 2.4× 103 0.9× 25 985
Marion Sparrius Netherlands 14 342 0.7× 330 0.8× 314 1.0× 224 1.3× 195 1.7× 18 946
Benjamin G. Schroeder United States 10 680 1.4× 974 2.4× 774 2.4× 129 0.8× 173 1.5× 11 1.6k
Gauranga Mukhopadhyay India 22 460 0.9× 267 0.6× 295 0.9× 88 0.5× 303 2.7× 41 1.1k

Countries citing papers authored by Michael V. Tullius

Since Specialization
Citations

This map shows the geographic impact of Michael V. Tullius's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael V. Tullius with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael V. Tullius more than expected).

Fields of papers citing papers by Michael V. Tullius

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael V. Tullius. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael V. Tullius. The network helps show where Michael V. Tullius may publish in the future.

Co-authorship network of co-authors of Michael V. Tullius

This figure shows the co-authorship network connecting the top 25 collaborators of Michael V. Tullius. A scholar is included among the top collaborators of Michael V. Tullius based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael V. Tullius. Michael V. Tullius is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
2.
Xu, Wenxi, Laura M. Snell, Mengdi Guo, et al.. (2021). Early innate and adaptive immune perturbations determine long-term severity of chronic virus and Mycobacterium tuberculosis coinfection. Immunity. 54(3). 526–541.e7. 27 indexed citations
3.
4.
Clemens, Daniel L., Bai‐Yu Lee, Michael V. Tullius, et al.. (2018). Nanoparticle Formulation of Moxifloxacin and Intramuscular Route of Delivery Improve Antibiotic Pharmacokinetics and Treatment of Pneumonic Tularemia in a Mouse Model. ACS Infectious Diseases. 5(2). 281–291. 13 indexed citations
5.
Cunningham, Cameron R., Ameya S. Champhekar, Michael V. Tullius, et al.. (2016). Type I and Type II Interferon Coordinately Regulate Suppressive Dendritic Cell Fate and Function during Viral Persistence. PLoS Pathogens. 12(1). e1005356–e1005356. 54 indexed citations
6.
Contreras, Heidi, Matthew S. Joens, Vincent Le, et al.. (2014). Characterization of a Mycobacterium tuberculosis Nanocompartment and Its Potential Cargo Proteins. Journal of Biological Chemistry. 289(26). 18279–18289. 77 indexed citations
7.
Gillis, Thomas P., Michael V. Tullius, & Marcus A. Horwitz. (2014). rBCG30-Induced Immunity and Cross-Protection against Mycobacterium leprae Challenge Are Enhanced by Boosting with the Mycobacterium tuberculosis 30-Kilodalton Antigen 85B. Infection and Immunity. 82(9). 3900–3909. 20 indexed citations
8.
Tullius, Michael V., Cedric P. Owens, Nicholas Chim, et al.. (2011). Discovery and characterization of a unique mycobacterial heme acquisition system. Proceedings of the National Academy of Sciences. 108(12). 5051–5056. 167 indexed citations
9.
Tullius, Michael V., Günter Harth, Saša Masleša-Galić, Barbara Jane Dillon, & Marcus A. Horwitz. (2008). A Replication-Limited Recombinant Mycobacterium bovis BCG Vaccine against Tuberculosis Designed for Human Immunodeficiency Virus-Positive Persons Is Safer and More Efficacious than BCG. Infection and Immunity. 76(11). 5200–5214. 63 indexed citations
11.
Tullius, Michael V., Günter Harth, & Marcus A. Horwitz. (2003). Glutamine Synthetase GlnA1 Is Essential for Growth of Mycobacterium tuberculosis in Human THP-1 Macrophages and Guinea Pigs. Infection and Immunity. 71(7). 3927–3936. 145 indexed citations
12.
Goon, Scarlett, Birgit Schilling, Michael V. Tullius, Bradford W. Gibson, & Carolyn R. Bertozzi. (2003). Metabolic incorporation of unnatural sialic acids into Haemophilus ducreyi lipooligosaccharides. Proceedings of the National Academy of Sciences. 100(6). 3089–3094. 40 indexed citations
13.
Tullius, Michael V., Nancy J. Phillips, Robert S. Munson, et al.. (2002). The lbgAB Gene Cluster of Haemophilus ducreyi Encodes a β-1,4-Galactosyltransferase and an α-1,6- dd -Heptosyltransferase Involved in Lipooligosaccharide Biosynthesis. Infection and Immunity. 70(6). 2853–2861. 25 indexed citations
15.
Schilling, Birgit, et al.. (2000). Cloning and Characterization of the Lipooligosaccharide Galactosyltransferase II Gene of Haemophilus ducreyi. Journal of Bacteriology. 182(8). 2292–2298. 20 indexed citations
16.
Bozue, Joel A., Michael V. Tullius, Jing Wang, Bradford W. Gibson, & Robert S. Munson. (1999). Haemophilus ducreyi Produces a Novel Sialyltransferase. Journal of Biological Chemistry. 274(7). 4106–4114. 59 indexed citations
17.
Tullius, Michael V., Willie F. Vann, & Bradford W. Gibson. (1999). Covalent modification of lys19 in the ctp binding site of cytidine 5′‐monophosphate n‐acetylneuraminic acid synthetase. Protein Science. 8(3). 666–675. 8 indexed citations
18.
Tullius, Michael V., Robert S. Munson, Jing Wang, & Bradford W. Gibson. (1996). Purification, Cloning, and Expression of a Cytidine 5′-Monophosphate -Acetylneuraminic Acid Synthetase from. Journal of Biological Chemistry. 271(26). 15373–15380. 51 indexed citations
19.
Melaugh, William, Nancy J. Phillips, Anthony A. Campagnari, Michael V. Tullius, & Bradford W. Gibson. (1994). Structure of the Major Oligosaccharide from the Lipooligosaccharide of Haemophilus ducreyi Strain 35000 and Evidence for Additional Glycoforms. Biochemistry. 33(44). 13070–13078. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026